David Wallis

David is motivated by the pursuit of working in partnership with clients to help them achieve their goals. His attention to detail, integrity and focus on results are all central to his approach.

He has over 13 years’ experience in investment banking, having worked with private businesses, publicly listed companies and private equity during this time.

Before joining 333 Capital, David worked with Bank of America Merrill Lynch and Macquarie Capital, as well as leading mid-market corporate finance boutiques in both London and Australia.

David’s areas of expertise include mergers and acquisitions, buy and sell-side advisory and public and private company capital raising.

David has a Master of Finance from INSEAD and a Juris Doctor of Law, Bachelor of Commerce and Bachelor of Science from the University of Queensland.

Significant engagements

• Ovato on its restructure and recapitalisation
• Connective on its sale to ASX listed Australian Finance Group (pending)
• Retail Food Group on its sale of Dairy Country to Fonterra
• Healthcare Australia on its sale to Crescent Capital
• KKR consortium on its acquisition of GE Consumer Finance (AUD 8.2 billion)
• TPG consortium/DTZ on its acquisition of Cushman & Wakefield (USD 2.0 billion)
• The Carlyle Group on its proposed acquisition of Genesis Care
• Wood Mackenzie (Charterhouse Capital Partners) on its sale to Hellman & Friedman (GBP 1.1 billion)
• Stylesight on its sale to WGSN
• Minerals Value Service on its partial sale and commercial partnership negotiation with Platts
• Mekentosj Papers on its sale to Springer Science+Business Media
• Mammoth Pet (Petbarn) on its capital raising from TPG Growth
• Dark Blue Sea on its response to takeover offer
• Wallace Absolute Return on its response to takeover offer
• Premium Investors on its share buy-back and response to shareholder action
• Western Desert Resources on its strategic review
• Ironbridge Capital on its acquisition of Bravura Solutions
• Airline Partners Australia on its takeover offer for Qantas ($11 billion)
• MFS on its strategic review
• ASX listed share placements and ANREOs (ASX: KPT, PAL, INA, GPR, EOS, BLK).